Entries of Apaolaza, P. S. on the publication server
![]() | Up a level |
Number of items: 3.
2024
Haase, André, Miroschnikov, Natalia, Klein, Stefan, Doege, Annika, Dünker, Nicole, Van Meenen, Dario, Junker, Andreas, Göpferich, Achim
, Apaolaza, P. S. and Busch, Maike Anna
(2024)
New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.
Molecular Oncology 18 (4), pp. 832-849.
Fulltext not available.
, Apaolaza, P. S. and Busch, Maike Anna
(2024)
New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.
Molecular Oncology 18 (4), pp. 832-849.
Fulltext not available.
2016
Apaolaza, P. S., del Pozo-Rodríguez, A., Solinís, M. A., Rodríguez, J. M., Friedrich, U., Torrecilla, J.
, Weber, Bernhard H. F.
and Rodríguez-Gascón, A.
(2016)
Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles.
Biomaterials 90, pp. 40-49.
Fulltext not available.
, Weber, Bernhard H. F.
and Rodríguez-Gascón, A.
(2016)
Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles.
Biomaterials 90, pp. 40-49.
Fulltext not available.
2015
Apaolaza, P. S., del Pozo-Rodríguez, A., Torrecilla, J.
, Rodríguez-Gascón, A., Rodríguez, J. M., Friedrich, Ulrike, Weber, Bernhard H. F.
and make_name_string expected hash reference
(2015)
Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model.
Journal of Controlled Release 217, pp. 273-283.
Fulltext not available.
, Rodríguez-Gascón, A., Rodríguez, J. M., Friedrich, Ulrike, Weber, Bernhard H. F.
and make_name_string expected hash reference
(2015)
Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model.
Journal of Controlled Release 217, pp. 273-283.
Fulltext not available.
